Keynote speaker Josh Sommer was recently named one of Forbes 30 Under 30 in Life Sciences and Healthcare. He discusses his rare cancer diagnosis while in college and his subsequent journey to become the Executive Director of The Chordoma Foundation. He also explains his search for information, insight and connections at the 2013 BIO International Convention.
Ron Stotish, CEO, AquaBounty Technologies, discusses AquAdvantage® Salmon, the first candidate application for a genetically modified (transgenic) food animal at the 2013 BIO International Convention.
Chris Morrison, Editor, Elsevier Business Intelligence, interviews Glen Giovannetti, Global Life Sciences Sector Leader, Ernst & Young about the newly released Beyond Borders Report at the 2013 BIO International Convention.
Published on Apr 23, 2013 David Kappos, former Director, US Patent and Trade Office and current Partner Cravath, Swaine and Moore, LLP discusses the Canadian Utility Requirement at the 2013 BIO International Convention.
Kathleen Ruddy, CEO of the St. Baldricks Foundation, the world's largest funder of childhood cancer research grants outside of the federal government explains the type of relationships they hope to develop at the 2013 BIO International Convention.
At the 2013 BIO International Convention, Rachel King discusses how we can enhance the climate for innovation with communication, strong and helpful FDA, and need to protect financial incentives so we can deliver the innovations.
